0001237899-19-000024.txt : 20191126 0001237899-19-000024.hdr.sgml : 20191126 20191126160228 ACCESSION NUMBER: 0001237899-19-000024 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191122 FILED AS OF DATE: 20191126 DATE AS OF CHANGE: 20191126 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VAGELOS P ROY CENTRAL INDEX KEY: 0001013064 STANDARD INDUSTRIAL CLASSIFICATION: AIRCRAFT [3721] STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 191250824 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2019-11-22 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001013064 VAGELOS P ROY 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 1 0 0 Chairman of the Board Common Stock 2019-11-14 5 G 0 40681 0.0 D 347824 D Common Stock 2019-11-21 5 G 0 7246 0.0 D 340578 D Common Stock 2019-11-22 4 M 0 46138 21.25 A 386716 D Common Stock 2019-11-22 4 F 0 23989 358.33 D 362727 D Common Stock 2019-11-22 5 G 0 14000 0.0 D 348727 D Common Stock 2019-11-25 5 G 0 22093 0.0 D 326634 D Common Stock 2019-11-25 4 S 0 156 358.92 D 326478 D Common Stock 2019-11-25 4 S 0 1479 359.46 D 324999 D Common Stock 2019-11-25 4 S 0 592 360.37 D 324407 D Common Stock 2019-11-25 4 S 0 2492 361.46 D 321915 D Common Stock 2019-11-25 4 S 0 2284 362.61 D 319631 D Common Stock 2019-11-25 4 S 0 3605 363.53 D 316026 D Common Stock 2019-11-25 4 S 0 3755 364.55 D 312271 D Common Stock 2019-11-25 4 S 0 3269 365.25 D 309002 D Common Stock 2019-11-25 4 S 0 4517 366.63 D 304485 D Common Stock 2019-07-02 5 G 0 669 0.0 D 145661 I by CLAT Common Stock 2019-10-02 5 G 0 764 0.0 D 144897 I by CLAT Common Stock 2326 I By 401(k) Plan Common Stock 83652 I by Spouse as Trustee Common Stock 1203 I by trust for grandch Non-Qualified Stock Option (right to buy) 21.25 2019-11-22 4 M 0 46138 0.0 D 2019-12-18 Common Stock 46138 107655 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 156 shares of Company stock on November 25, 2019 at prices ranging from $358.68 to $358.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 25, 2019 at each separate price. Represents volume-weighted average price of sales of 1,479 shares of Company stock on November 25, 2019 at prices ranging from $359.05 to $359.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 25, 2019 at each separate price. Represents volume-weighted average price of sales of 592 shares of Company stock on November 25, 2019 at prices ranging from $360.01 to $360.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 25, 2019 at each separate price. Represents volume-weighted average price of sales of 2,492 shares of Company stock on November 25, 2019 at prices ranging from $361.06 to $361.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 25, 2019 at each separate price. Represents volume-weighted average price of sales of 2,284 shares of Company stock on November 25, 2019 at prices ranging from $362.02 to $362.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 25, 2019 at each separate price. Represents volume-weighted average price of sales of 3,605 shares of Company stock on November 25, 2019 at prices ranging from $363.00 to $363.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 25, 2019 at each separate price. Represents volume-weighted average price of sales of 3,755 shares of Company stock on November 25, 2019 at prices ranging from $364.04 to $364.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 25, 2019 at each separate price. Represents volume-weighted average price of sales of 3,269 shares of Company stock on November 25, 2019 at prices ranging from $365.02 to $365.71. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 25, 2019 at each separate price. Represents volume-weighted average price of sales of 4,517 shares of Company stock on November 25, 2019 at prices ranging from $366.07 to $366.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 25, 2019 at each separate price. By a trust for the benefit of certain grandchildren of the reporting person, of which the reporting person and/or the spouse of the reporting person is trustee. The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant. /s/**P. Roy Vagelos 2019-11-26